EUVIMEDEUVIMED entdecken
Open Access

Leveraging Patient-Derived Organoids for Personalized Liver Cancer Treatment

Jianhua Rao, Chao Song, Yangyang Hao, Zaozao Chen, Sidu Feng, Shihui Xu, Xiaoyue Wu, Zhengfeng Xuan, Ye Fan, Wenzhu Li, Junda Li, Yong Ren und 3 weitere

International Journal of Biological Sciences · 2024 · 20 (13) · 5363-5374

DOI: 10.7150/ijbs.96317 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2024. Verfasst von Jianhua Rao und 14 weiteren Autor:innen. Beteiligte Einrichtung: Hepatobiliary Center of The First Affiliated Hospital, Nanjing Medical University; Research Unit of Liver Transplantation and Transplant Immunology, …. Hauptthemen laut MEDLINE: Organoids, Liver Neoplasms, Precision Medicine. Die Arbeit wurde bisher 23-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OrganoidsLiver NeoplasmsPrecision MedicineHumansMaleFemaleMiddle AgedAgedMutationAntineoplastic AgentsAdultDNA Copy Number Variations

Stichwörter der Autor:innen

drug screeningorganoidpersonalized treatmentprimary liver cancer

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Hepatobiliary Center of The First Affiliated Hospital, Nanjing Medical University; Research Unit of Liver Transplantation and Transplant Immunology, Chinese Academy of Medical Sciences, Nanjing, China.
  • State Key Laboratory of Digital Medical Engineering, Southeast University, Nanjing, China.
  • School of Biological Science & Medical Engineering, Southeast University, Nanjing, China.
  • Key Laboratory of DGHD, MOE, School of Life Science and Technology, Southeast University, Nanjing, China.
  • Jiangsu Avatarget Co, Suzhou, China.
  • Institute of Medical Devices (Suzhou), Southeast University, Nanjing, China.

Zitieren

APA

Rao, J., Song, C., Hao, Y., Chen, Z., Feng, S., Xu, S., Wu, X., Xuan, Z., Fan, Y., Li, W., Li, J., Ren, Y., Li, J., Cheng, F., & Gu, Z. (2024). Leveraging Patient-Derived Organoids for Personalized Liver Cancer Treatment. International Journal of Biological Sciences, 20(13), 5363-5374. https://doi.org/10.7150/ijbs.96317

Vancouver

Rao J, Song C, Hao Y, Chen Z, Feng S, Xu S, et al. Leveraging Patient-Derived Organoids for Personalized Liver Cancer Treatment. International Journal of Biological Sciences. 2024;20(13):5363-5374. doi:10.7150/ijbs.96317

BibTeX
@article{Rao2024,
  author = {Rao, Jianhua and Song, Chao and Hao, Yangyang and Chen, Zaozao and Feng, Sidu and Xu, Shihui and Wu, Xiaoyue and Xuan, Zhengfeng and Fan, Ye and Li, Wenzhu and Li, Junda and Ren, Yong and Li, Jian and Cheng, Feng and Gu, Zhongze},
  title = {Leveraging Patient-Derived Organoids for Personalized Liver Cancer Treatment},
  journal = {International Journal of Biological Sciences},
  year = {2024},
  volume = {20},
  number = {13},
  pages = {5363--5374},
  doi = {10.7150/ijbs.96317}
}
Kostenlos starten →